(This story has been refiled to fix the reference to 'unreasonable' risk, in paragraph 11)
WASHINGTON (Reuters) - Elon Musk's announcement this week that his startup Neuralink had implanted the first human patient with its experimental brain device generated immediate buzz.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
